ChemoGel - A thermoresponsive hydrogel for interventional oncology applications   Licensing Opportunity from RCSI June 2017 front page preview

ChemoGel - A thermoresponsive hydrogel for interventional oncology applications Licensing Opportunity from RCSI June 2017

Thermoresponsive hydrogels have attracted significant attention for drug delivery due to their ability to phase-transition from an injectable liquid at room temperatures to a solid gel at physiological temperatures. Howe...

pdf 507.4KB

PanaColl- A collagen-based scaffold for the delivery of antibiotics and enhancement of tissue regeneration Licensing Opportunity for RCSI June 2017 front page preview

PanaColl- A collagen-based scaffold for the delivery of antibiotics and enhancement of tissue regeneration Licensing Opportunity for RCSI June 2017

Osteomyelitis (OM) is an infection of bone caused by bacteria such as Staphylococcus Aureus (S. Aureus). The current gold standard treatment for chronic OM is debridement of the infected bone followed by administration o...

pdf 462.2KB

Objective medication adherence calculator A tool to aid patient adherence and optimise drug dosage Licensing Opportunity for RCSI June 2017 front page preview

Objective medication adherence calculator A tool to aid patient adherence and optimise drug dosage Licensing Opportunity for RCSI June 2017

Assessing adherence to medication is an essential element in the ongoing treatment of patients with chronic disease as well as in the development and trialling of new drugs. The current standard methods of adherence asse...

pdf 379.5KB

A computer-implemented system and method for the prediction of cancer response to genotoxic chemotherapy and personalised neoadjuvant treatments PCCP Licensing Opportunity From RCSI June 2017 front page preview

A computer-implemented system and method for the prediction of cancer response to genotoxic chemotherapy and personalised neoadjuvant treatments PCCP Licensing Opportunity From RCSI June 2017

Recognising the central role apoptosis deficiency plays in poor cancer treatment responsiveness, a team of translational systems biology researchers at RCSI have developed a Prediction model of Cancer Response to Genotox...

pdf 223.5KB

FLEXAROD - An innovative flexible spinal instrumentation system for Minimally Invasive Spinal Surgery (MISS) - Licensing Opportunity from National University of Ireland Galway - April 2017 front page preview

FLEXAROD - An innovative flexible spinal instrumentation system for Minimally Invasive Spinal Surgery (MISS) - Licensing Opportunity from National University of Ireland Galway - April 2017

NUIG’s technology allows easy insertion of the implant rod while its’ intrinsic design can address longer and stronger spine curves as they appear in more than 3 level fusions. Its results in greater bone and ligament pr...

pdf 1.2MB